A Resilience-Based Approach to Improve Long-term Quality of Life in Post-treatment Lymphoma Survivorship
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The goal of this trial is to learn if a resilience intervention can lead to improvements in lymphoma survivors' quality of life.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Dorośli mówiący po angielsku lub hiszpańsku (od 18 lat w momencie rozpoczęcia badania)
- •Minęło od 1 do 5 lat od zakończenia aktywnego leczenia chłoniaka (np. operacji, chemioterapii, immunoterapii, radioterapii). Można brać udział, nawet jeśli stosuje się leczenie podtrzymujące.
✗ Disqualifies
- •Osoby z aktywnymi problemami psychicznymi, medycznymi lub trudnościami w rozumieniu (oceniane przez lekarza prowadzącego badanie).
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- September 28, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (2)
Mass General Hospital
Boston, United States
Huntsman Cancer Institute
Salt Lake City, United States
Trial contact
Giselle K Perez, PhD
Giselle K Perez, PhD
PRINCIPAL_INVESTIGATOR
Anne Kirchhoff, PhD
Anne Kirchhoff, PhD
PRINCIPAL_INVESTIGATOR
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 9/29/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.